Literature DB >> 8706755

Isolation and expression of a cDNA clone encoding human kynureninase.

D Alberati-Giani1, R Buchli, P Malherbe, C Broger, G Lang, C Köhler, H W Lahm, A M Cesura.   

Abstract

Kynureninase (L-kynurenine hydrolase), a pyridoxal-5'-phosphate-(pyridoxal-P)-dependent enzyme, catalyses the cleavage of L-kynurenine and L-3-hydroxykynurenine into anthranilic and 3-hydroxyanthranilic acids, respectively. In this report, we describe the isolation of a cDNA clone encoding human kynureninase. Degenerate oligonucleotides designed from the amino acid sequences of peptides from rat liver kynureninase, were used as primers for reverse-transcription PCR of rat kidney RNA. The resulting rat cDNA product was then used to screen a human hepatoma cell line (Hep G2) cDNA library. Analysis of a positive cDNA clone showed the presence of an insert of 1651 nucleotides containing an open reading frame coding for a protein of 456 amino acids (theoretical molecular mass = 52357 Da). The predicted amino acid sequence of human kynureninase displayed high similarity to that reported for the rat enzyme and to a Saccharomyces cerevisiae gene product putatively ascribed to kynureninase. Profile analysis of kynureninase primary structure indicated the presence of a pyridoxal-P-binding site consensus sequence assigned to class-V aminotransferases, with Lys276 being the residue binding the cofactor. RNA blot analysis of human tissues, including brain, showed the presence of an approximately 2.0-kb mRNA species in all tissues tested. A second mRNA species (approximately 2.6 kb) was also detected in some tissues. After transfection of HEK-293 cells with the cDNA coding for kynureninase, the K(m) values of L-kynurenine and DL-3-hydroxykynurenine for the recombinant enzyme were 671 +/- 37 microM and 13.2 +/- 2.0 microM, respectively.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8706755     DOI: 10.1111/j.1432-1033.1996.0460u.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

1.  Purification and molecular cloning of rat 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase.

Authors:  Atsushi Tanabe; Yukari Egashira; Shin-Ichi Fukuoka; Katsumi Shibata; Hiroo Sanada
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

Review 2.  Kynurenines in the CNS: recent advances and new questions.

Authors:  László Vécsei; Levente Szalárdy; Ferenc Fülöp; József Toldi
Journal:  Nat Rev Drug Discov       Date:  2012-12-14       Impact factor: 84.694

3.  Crystal structure of the Anopheles gambiae 3-hydroxykynurenine transaminase.

Authors:  Franca Rossi; Silvia Garavaglia; Giovanni Battista Giovenzana; Bruno Arcà; Jianyong Li; Menico Rizzi
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

Review 4.  Tryptophan-kynurenine pathway is dysregulated in inflammation, and immune activation.

Authors:  Qiongxin Wang; Danxia Liu; Ping Song; Ming-Hui Zou
Journal:  Front Biosci (Landmark Ed)       Date:  2015-06-01

5.  Xanthurenic aciduria due to a mutation in KYNU encoding kynureninase.

Authors:  M Christensen; M Duno; A M Lund; F Skovby; E Christensen
Journal:  J Inherit Metab Dis       Date:  2007-03-01       Impact factor: 4.750

6.  The role of anthranilic acid in the increase of depressive symptoms and major depressive disorder during treatment for hepatitis C with pegylated interferon-α2a and oral ribavirin.

Authors:  Tomasz Pawlowski; Dariusz Pawlak; Malgorzata Inglot; Malgorzata Zalewska; Dominik Marciniak; Jolanta Bugajska; Justyna Janocha-Litwin; Krzysztof Malyszczak
Journal:  J Psychiatry Neurosci       Date:  2021-01-18       Impact factor: 6.186

7.  Upregulated Kynurenine Pathway Enzymes in Aortic Atherosclerotic Aneurysm: Macrophage Kynureninase Downregulates Inflammation.

Authors:  Masanori Nishimura; Atsushi Yamashita; Yunosuke Matsuura; Junichi Okutsu; Aiko Fukahori; Tsuyoshi Hirata; Tomohiro Nishizawa; Hirohito Ishii; Kazunari Maekawa; Eriko Nakamura; Kazuo Kitamura; Kunihide Nakamura; Yujiro Asada
Journal:  J Atheroscler Thromb       Date:  2020-12-10       Impact factor: 4.928

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.